Pfizer, Tris Pharma settle for $41.5m in Texas ADHD drug case
Texas's top prosecutor on Wednesday announced the state had reached a $41.5 million settlement with US drugmakers Pfizer and Tris Pharma, over allegations of drug adulteration and defrauding the state's Medicaid program.
The post Pfizer, Tris Pharma settle for $41.5m in Texas ADHD drug case appeared first on Vanguard News.
